Volteface
@VoltefaceHub
Followers
9K
Following
10K
Media
2K
Statuses
15K
We are an advocacy and communications organisation. Our content platform cultivates fresh thinking and new ideas to reduce drug related harm.
London, UK
Joined October 2015
RT @VoltefaceHub: Breaking: @lyphedispensary has launched the V range to UK patients. Find out more about what that means for patients and….
0
2
0
Breaking: @lyphedispensary has launched the V range to UK patients. Find out more about what that means for patients and the sector below 👇.
3
2
5
RT @Paul__North: Nice milestone for the new business - our first commercial filming job for the @UKCanCouncil at @Fieldfisher Law Firm. C….
0
3
0
RT @MedCanProject: Our research findings and policy recommendations highlighted in this article by @VoltefaceHub on the “hidden harms” face….
0
2
0
Kamala Harris has taken a bold step, endorsing full cannabis legalisation. She emphasised the need to stop criminalising cannabis use, particularly for marginalised communities disproportionately affected by drug laws. Read more:.
0
0
0
5/ The study calls for education, reform, and better access to NHS prescriptions to reduce inequality. Full article and breakdown here: .
0
0
6
4/ Social stigma forces patients to hide their use or justify it as "medical," perpetuating the divide between recreational and medical users.
1
0
4
3/ Encounters with police cause anxiety, particularly for marginalised groups. Even with prescriptions, cannabis users feel at risk.
2
0
5
2/ Patients report stigma in healthcare, where professionals lack training or dismiss cannabis as an illicit drug—even when legally prescribed.
1
0
4
🧵1/ Cannabis has been legal for medical use in the UK since 2018, but patients still face stigma. A new study explores how prohibitionist attitudes persist. 👇.
3
17
29
8/ The rise in ketamine use demands action, not panic. Let’s ensure young people are empowered with the knowledge and support they need to make safer decisions. #DrugEducation #HarmReduction #Ketamine.
0
0
0
7/ Schools, universities, and harm reduction services must offer up-to-date, evidence-based education on ketamine’s risks, focusing on safer use and treatment options. Prevention starts with awareness! 🧠.
1
0
0
6/ While we’re not looking at a major crisis, we do need better drug education and harm reduction strategies. Many young people view ketamine as relatively "safe," but long-term health risks like bladder damage are often overlooked.
1
0
0
5/ Despite its rising popularity, ketamine doesn’t feature prominently in drug-related death stats. Roughly 30 deaths annually are linked to ketamine, often combined with other substances.
1
0
0
4/ One of the biggest health risks associated with ketamine misuse is "ketamine bladder," a condition causing severe urinary tract damage. Since 2019, NHS urologists have reported an “explosion” in cases, but data remains vague.
1
0
0
3/ The number of young people seeking treatment for ketamine misuse has also risen, from 512 in 2021/22 to 719 in 2022/23. Among adults, treatment cases rose from 1,551 to 2,211 over the same period. 🚨.
1
0
0
2/ In 2021, 0.6% of 11-15-year-olds reported using ketamine in the past year—down from 1% in 2018. Among 16-24-year-olds, usage rose to 3.8% in 2022/23 from 3.2% in 2019/20. A growing trend, but not an explosion. 📊.
1
0
0
🧵 Is Ketamine Use Among Young People in the UK a Growing Crisis?. 1/ Recent data shows an increase in ketamine use among young people, but is it a crisis or a moderate rise? Let's dive into the stats and health impacts of this dissociative drug.
2
2
4
🔄 Industry Impact: These updates bring CBPMs in line with other unlicensed medicines. While improving quality, they may cause short-term disruptions for businesses and patients alike. #CannabisIndustry. (6/6). Read here:
1
0
0